Inventor · London, GB

John Francis Lyons

14Patents
6h-index
35Co-inventors
66Inventor score

Filing activity: May 22, 1998 → Mar 28, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US6998391B2 Method for treating diseases associated with abnormal kinase activity Human Necessities 80 Expired
US6187799A Inhibition of raf kinase activity using aryl ureas Chemistry; Metallurgy 53 Expired
US8399442B2 Pharmaceutical compounds Chemistry; Metallurgy 41 Active
US8277807B2 Pharmaceutical combinations Human Necessities 31 Active
US7307071B2 RAF-MEK-ERK pathway inhibitors to treat cancer Human Necessities 22 Expired
US8435970B2 Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea Human Necessities 8 Active
US8404718B2 Combinations of pyrazole kinase inhibitors Human Necessities 5 Active
US11236047B2 Combination of isoindolinone derivatives with SGI-110 Human Necessities 2 Active
US8916552B2 Pharmaceutical combinations Human Necessities 2 Active
US8779132B2 Pharmaceutical compounds Chemistry; Metallurgy 2 Active
US8883790B2 Pharmaceutical combinations Human Necessities 2 Active
US9428439B2 Hydrobenzamide derivatives as inhibitors of Hsp90 Chemistry; Metallurgy 2 Active
US8541461B2 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators Human Necessities 1 Active
US6977247B2 Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.